The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound

Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

[search][options]

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

W. Robert Simons

Global Health Economics and Outcomes Research Inc

Summit

NJ 07901

USA

[email]@globalhealtheconomics.com

Name/email consistency: high

[Claim this account]

Affiliation

Global Health Economics and Outcomes Research Inc, Summit, NJ 07901, USA. 2003 - 2012

References

The economic consequences of rheumatoid arthritis: analysis of Medical Expenditure Panel Survey 2004, 2005, and 2006 data. Simons, W.R., Rosenblatt, L.C., Trivedi, D.N. J. Occup. Environ. Med. (2012) [Pubmed]
An economic evaluation of colesevelam when added to metformin-, insulin- or sulfonylurea-based therapies in patients with uncontrolled type 2 diabetes mellitus. Simons, W.R., Hagan, M.A. Pharmacoeconomics (2010) [Pubmed]
Does rapid transition to insulin therapy in subjects with newly diagnosed type 2 diabetes mellitus benefit glycaemic control and diabetes-related complications? A German population-based study. Simons, W.R., Vinod, H.D., Gerber, R.A., Bolinder, B. Exp. Clin. Endocrinol. Diabetes (2006) [Pubmed]
The economic value of lamotrigine as a mood stabilizer: a U.S. managed care perspective. Simons, W.R., Krishnan, A.A. Manag. Care. Interface (2004) [Pubmed]
Cost-effectiveness of anastrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer. Simons, W.R., Jones, D., Buzdar, A. Clin. Ther (2003) [Pubmed]